Category Archives: XBI-26-10

Biotech follows Amgen … Down

September 8, 2026 By in Biotech, IBB, AMGN, SPBIO, $SPSIBI, XBI, XBI-26-10, IBB-26-05

IBB, Below Support

Amgen was whacked for a -10.08% loss during today’s session.

Biotech IBB, XBI, followed suit; down -2.17% and -1.15%, respectively.

Both indexes retraced during the day; it was noted XBI’s retrace was 50%, while IBB’s retrace as 38%.

Therefore, the trading response was to close short-trade XBI-26-10 (for profit), re-establish that short via IBB, as IBB-26-05 (not advice, not a recommendation).

Note in the chart above, the last time IBB pushed below support, it was in spring position and moved higher the next three sessions.

Markets tend to alternate.

Let’s see what happens next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Tesla ‘Channel’

September 6, 2026 By in Transportation, TSLA, XBI, XBI-26-10

Right Way … Wrong Way

Potential false upside breakout moves from a down-channel, have happened before.

Once such occurrence, was here.

Let’s see if the trendline was drawn correctly, or not.

The segment is a closer view of where TSLA left-off last Friday.

If it’s in the channel, watch for a lower open and acceleration lower (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Moderna ‘Stretched’

September 5, 2026 By in Biotech, MRNA, SPBIO, XBI, XBI-26-10

The Most, Ever

The effect of Moderna’s single day +176.97% move, can be directly seen in biotech XBI gaining +5.90%, the same day.

Since then, it’s been just over two-weeks and already, Wall St. has ‘cooled‘ to Moderna.

You can’t make this up. 🙂

With that said, and from a market behavior standpoint alone, wide high-volume price bars, tend to be tested (not advice, not a recommendation).

Moderna MRNA, Weekly

With MRNA slamming into resistance, highest volume, widest bar, ever, sort of says ‘Ruh Roh‘.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (short) Close-Up

September 4, 2026 By in Biotech, XBI, XBI-26-10

Documenting The Trade

Yesterday’s trade was a stretch to go short on biotech XBI, without (confirmation) posting a new daily low (yet),

Today, the new daily low … just barely.

What that does from a trading standpoint, is provide a definitive stop; yesterday’s high (not advice, not a recommendation).

From the chart, we’re at the edge of congestion with price action struggling to make new highs … that so far, are not happening.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech at The Edge (again)

September 3, 2026 By in $SPSIBI, ABNB, Biotech, CVNA, KMX, LABD, LABD-26-10, SPBIO, XBI, XBI-26-10 1 Comment

Is The Top, In?

Whether it’s Biotech XBI, Airbnb, CarMax or Carvana, trade set-ups are being worked that take place at the ‘edge of congestion.’

The last update on XBI, was here, August 24th, nine trading days ago.

The short, LABD-26-10 was immediately stopped out at the next session.

The index labored on, grinding in a range while posting a bearish MACD divergence on daily and weekly.

All of which, brings us to now.

The chart shows today’s action could not close above the resistance area posted back in July (not advice, not a recommendation).

There’s been no new daily low (yet).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279